Robert J. Spiegel Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Robert J. Spiegel.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Robert J. Spiegel. Robert J. Spiegel is a Director in Capstone Therapeutics Corp. ($CAPS) and a Director in GERON CORP ($GERN) and a Director in Cyclacel Pharmaceuticals, Inc. ($CYCC) and a Chief Medical Officer in PTC THERAPEUTICS, INC. ($PTCT) and a Director in Athenex, Inc. ($ATNX) and a Director in Sucampo Pharmaceuticals, Inc. ($SCMP) and a Director in Edge Therapeutics, Inc. ($EDGE).

Address: 1275 WEST WASHINGTON STREET SUITE 101 TEMPE 85281 AZ

Companies in which Robert J. Spiegel is an Insider

Athenex, Inc.

Trading Symbol: ATNX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Robert J. Spiegel: Director
Holdings: 0 shares
Latest Transaction: Aug 12 2020

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Capstone Therapeutics Corp.

Trading Symbol: CAPS
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Robert J. Spiegel: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: May 25 2010
$CAPS Market Capitalization: $3.48M
$CAPS Previous Close: $0.09

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Cyclacel Pharmaceuticals, Inc.

Trading Symbol: CYCC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Robert J. Spiegel: Director
Holdings: 0 shares
Latest Transaction: Jun 29 2020

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

GERON CORP

Trading Symbol: GERN
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Robert J. Spiegel: Director
Holdings: 119,497 shares
Current Value: $249,749
Latest Transaction: May 13 2021
$GERN Market Capitalization: $331.02M
$GERN Previous Close: $2.09

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

PDS Biotechnology Corp

Trading Symbol: EDGE
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Robert J. Spiegel: Director
Holdings: 48,661 shares
Current Value: $464,713
Latest Transaction: Mar 18 2019
$EDGE Market Capitalization: $272.98M
$EDGE Previous Close: $9.55

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

PTC THERAPEUTICS, INC.

Trading Symbol: PTCT
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Robert J. Spiegel: Chief Medical Officer
Holdings: 3,239 shares
Current Value: $43,597
Latest Transaction: Jan 06 2016
$PTCT Market Capitalization: $452.34M
$PTCT Previous Close: $13.46

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Sucampo Pharmaceuticals, Inc.

Trading Symbol: SCMP
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Robert J. Spiegel: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Feb 13 2018
$SCMP Market Capitalization: $496.69M
$SCMP Previous Close: $11.35

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of Robert J. Spiegel

Sentiment: All, ATNX, CAPS, CYCC, GERN, EDGE, PTCT, SCMP

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
May 13 2021	GERN	GERON CORP	Spiegel Robert J.	Director	Option Exercise	A	1.39	83,000	115,370	83,000
Apr 02 2021	GERN	GERON CORP	Spiegel Robert J.	Director	Grant	A	0.00	4,549	0	119,497	114.9 K to 119.5 K (+3.96 %)
Jan 11 2021	GERN	GERON CORP	Spiegel Robert J.	Director	Grant	A	0.00	4,520	0	114,948	110.4 K to 114.9 K (+4.09 %)
Oct 02 2020	GERN	GERON CORP	Spiegel Robert J.	Director	Grant	A	0.00	4,130	0	110,428	106.3 K to 110.4 K (+3.89 %)
Aug 12 2020	ATNX	Athenex, Inc.	Spiegel Robert J.	Director	Option Exercise	A	11.40	7,292	83,129	7,292
Jul 02 2020	GERN	GERON CORP	Spiegel Robert J.	Director	Grant	A	0.00	3,297	0	106,298	103 K to 106.3 K (+3.20 %)
Jun 29 2020	CYCC	Cyclacel Pharmaceu ...	Spiegel Robert J.	Director	Option Exercise	A	4.70	5,200	24,440	5,200

View all Robert J. Spiegel insider transactions.